Bornyl acetate is a piney, balsamic monoterpene ester found widely in conifer, rosemary, cistus, and valerian oils across the AromaForge archive. Compared with many minor aroma constituents, it has a relatively usable public literature base: identity and flavor-safety sources are strong, while direct bioactivity evidence is mostly preclinical, with one small controlled human inhalation study on autonomic relaxation and several anti-inflammatory cell or animal papers. That makes bornyl acetate suitable for chemistry- and evidence-led archive copy, but not for medical claims.
Chemical identity and composition
PubChem and NIST both resolve bornyl acetate as a borneol-derived acetate ester with formula C12H20O2 and camphane skeleton isomerism. The archive already records bornyl acetate as a major or characteristic constituent in black spruce, rosemary verbenone, cistus, valerian root, and multiple fir and pine profiles, often at double-digit percentages in conifer-leaning oils.
Aroma and practical use
- Use the recorded pine, camphoraceous, balsamic, woody, herbal, piney, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2014 human chondrocyte study reported that bornyl acetate elevated IL-11 and reduced IL-1beta-associated IL-6, IL-8, MMP-1, and MMP-13 signals through a c-fos-linked mechanism.
A 2014 human chondrocyte study reported that bornyl acetate elevated IL-11 and reduced IL-1beta-associated IL-6, IL-8, MMP-1, and MMP-13 signals through a c-fos-linked mechanism.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2014 mouse acute-lung-injury paper found that bornyl acetate lowered inflammatory cell counts and cytokines in bronchoalveolar lavage fluid, reduced lung histologic injury, and was correlated with reduced myeloperoxidase activity.
A 2014 mouse acute-lung-injury paper found that bornyl acetate lowered inflammatory cell counts and cytokines in bronchoalveolar lavage fluid, reduced lung histologic injury, and was correlated with reduced myeloperoxidase activity.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2011 controlled odor-exposure study reported that low-dose inhaled (-)-bornyl acetate induced autonomic relaxation and reduced arousal after visual display terminal work without harming task performance.
A 2011 controlled odor-exposure study reported that low-dose inhaled (-)-bornyl acetate induced autonomic relaxation and reduced arousal after visual display terminal work without harming task performance.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
A 2023 review concluded that bornyl acetate has promising anti-inflammatory and immunomodulatory pharmacology, but the evidence base it summarizes is still dominated by preclinical models.
A 2023 review concluded that bornyl acetate has promising anti-inflammatory and immunomodulatory pharmacology, but the evidence base it summarizes is still dominated by preclinical models.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedWHO JECFA lists bornyl acetate as having no safety concern at current levels of intake when used as a flavouring agent.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
That food-flavouring conclusion does not establish a constituent-specific dermal limit, inhalation exposure limit, or pregnancy-use recommendation for isolated bornyl acetate.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No constituent-specific IFRA-style topical restriction or modern human tolerability study for isolated bornyl acetate was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
il 11 induction in chondrocytes
A human chondrocyte paper reported that bornyl acetate increased IL-11 expression and that the resulting IL-11 signal reduced IL-1beta-associated inflammatory mediators including IL-6, IL-8, MMP-1, and MMP-13.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
nf kb and mapk linked lung inflammation modulation
In an LPS acute-lung-injury model, bornyl acetate lowered pro-inflammatory cytokines and correlated with reduced myeloperoxidase activity plus suppression of NF-kappa-B- and MAPK-linked inflammatory signaling.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
regulatory flavor safety context
WHO JECFA lists bornyl acetate as presenting no safety concern at current levels of intake when used as a flavouring agent, which supports ingestion-at-flavor-dose context only and should not be stretched into topical or therapeutic safety claims.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Most direct bornyl-acetate bioactivity evidence remains preclinical despite the comparatively large literature footprint.
- No constituent-specific dermal limit, IFRA restriction, or robust inhalation safety framework for isolated bornyl acetate was verified in this pass.
- Human evidence is narrow and includes a small odor-exposure study rather than disease-treatment trials.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.